Lasa Supergenerics Ltd LASA-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 03/05/21 IST
70.00quote price arrow down-2.00 (-2.78%)
Volume
179,263
52 week range
25.50 - 100.90

...

Loading . . .

KEY STATS

  • Open72.10
  • Day High74.25
  • Day Low69.10
  • Prev Close72.00
  • 52 Week High100.90
  • 52 Week High Date01/08/21
  • 52 Week Low25.50
  • 52 Week Low Date03/30/20
  • Market Cap38.95M
  • Shares Out40.67M
  • 10 Day Average Volume260,913.27
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change58.19

RATIOS/PROFITABILITY

  • EPS (TTM)5.29
  • P/E (TTM)13.22
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Lasa Supergenerics Ltd News

There is no recent news for this security.

Latest LASA-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Lasa Supergenerics Limited is an India-based company engaged in the manufacturing of anthelmintics/veterinary active pharmaceutical ingredient (API). The Company also manufactures bulk drugs. Its product categories include veterinary API products, other API products, animal feed ingredients and reagents for therapeutic use. Its veterinary API products include toldimphos sodium, triclabendazole, rafoxanide, closantel sodium and oxyclozanide. other api products include povidone...
Omkar Herlekar
Chairman
Hema Iyer
Chief Financial Officer
Address
Mumbai
400059
India